Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Daisy Alapat

Concepts (252)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
30
2025
3013
1.910
Why?
Flow Cytometry
5
2018
396
0.880
Why?
Immunoglobulins
2
2018
76
0.660
Why?
Plasma Cells
3
2025
233
0.630
Why?
Immunoglobulin kappa-Chains
2
2016
22
0.590
Why?
Bone Marrow
7
2022
354
0.550
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2025
123
0.550
Why?
DNA, Neoplasm
1
2018
146
0.530
Why?
Hematopoietic Stem Cell Transplantation
4
2024
600
0.510
Why?
Lymphoma, Large B-Cell, Diffuse
2
2015
108
0.500
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2016
58
0.480
Why?
Neoplasm, Residual
6
2025
169
0.470
Why?
Immunoglobulin lambda-Chains
1
2015
15
0.470
Why?
Gene Rearrangement, B-Lymphocyte
1
2015
6
0.450
Why?
Receptors, Antigen, B-Cell
1
2015
7
0.450
Why?
Tumor Microenvironment
4
2024
257
0.420
Why?
Humans
50
2025
52441
0.390
Why?
Plasmacytoma
3
2022
44
0.370
Why?
Cell Differentiation
1
2015
667
0.370
Why?
Lymphoma, Mantle-Cell
1
2012
18
0.360
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2012
12
0.360
Why?
Carcinoembryonic Antigen
1
2011
13
0.350
Why?
Calcitonin
1
2011
30
0.340
Why?
Antigens, CD
1
2012
213
0.340
Why?
Middle Aged
20
2025
13133
0.320
Why?
Prognosis
9
2025
2100
0.310
Why?
Carcinoma
1
2011
135
0.310
Why?
Myogenin
1
2008
4
0.300
Why?
Muscle Fibers, Slow-Twitch
1
2008
12
0.300
Why?
Muscle Fibers, Fast-Twitch
1
2008
14
0.300
Why?
Paraproteinemias
2
2022
72
0.280
Why?
Gene Expression Profiling
4
2025
1099
0.270
Why?
Positron-Emission Tomography
3
2025
297
0.270
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1020
0.260
Why?
Neoplasms, Second Primary
2
2019
75
0.250
Why?
Aged
18
2025
10242
0.240
Why?
Female
23
2025
28277
0.230
Why?
Male
20
2025
26874
0.230
Why?
Treatment Outcome
10
2022
5508
0.230
Why?
Pancytopenia
3
2016
37
0.220
Why?
Diffusion Magnetic Resonance Imaging
1
2025
131
0.220
Why?
Gastrointestinal Neoplasms
1
2022
41
0.190
Why?
Embolization, Therapeutic
2
2021
93
0.180
Why?
Neoplasms, Plasma Cell
2
2020
35
0.180
Why?
Thrombocytopenia
1
2022
93
0.180
Why?
Chromosome Deletion
2
2023
138
0.170
Why?
Cryosurgery
1
2021
36
0.170
Why?
Skin Neoplasms
2
2016
496
0.170
Why?
Transplantation, Autologous
4
2024
479
0.160
Why?
Adult
11
2025
14205
0.160
Why?
Combined Modality Therapy
1
2021
641
0.150
Why?
Ploidies
1
2018
10
0.140
Why?
Hematopoietic Stem Cells
1
2019
180
0.140
Why?
Phenotype
2
2025
792
0.140
Why?
Leukemia, Myeloid, Acute
1
2019
202
0.140
Why?
Kidney Diseases
1
2020
230
0.140
Why?
Herpesvirus 8, Human
1
2019
97
0.140
Why?
Immunohistochemistry
3
2016
977
0.130
Why?
Sarcoma, Myeloid
1
2017
20
0.130
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.130
Why?
Lymph Nodes
2
2019
253
0.130
Why?
Amyloidosis
2
2016
85
0.130
Why?
Cell Cycle
1
2018
236
0.130
Why?
CA-125 Antigen
1
2016
16
0.130
Why?
Disease Progression
4
2025
870
0.120
Why?
Registries
3
2025
638
0.120
Why?
Skin Diseases, Infectious
1
2016
8
0.120
Why?
Leukemia, Promyelocytic, Acute
1
2016
11
0.120
Why?
Anemia, Aplastic
1
2016
10
0.120
Why?
Myeloproliferative Disorders
1
2016
32
0.120
Why?
Electrophoresis, Capillary
1
2015
10
0.120
Why?
In Situ Hybridization
1
2015
69
0.120
Why?
Tumor Suppressor Protein p53
1
2017
224
0.120
Why?
V(D)J Recombination
1
2015
4
0.110
Why?
Immunophenotyping
1
2015
115
0.110
Why?
Diagnosis, Differential
3
2016
1028
0.110
Why?
RNA, Messenger
2
2015
1134
0.110
Why?
Fatal Outcome
1
2015
193
0.110
Why?
Bone Marrow Transplantation
2
2022
110
0.110
Why?
Immunoglobulin Light Chains
1
2015
90
0.110
Why?
Prealbumin
1
2014
22
0.110
Why?
Bone Marrow Neoplasms
1
2014
13
0.110
Why?
Neoplasm Proteins
1
2016
328
0.110
Why?
Aged, 80 and over
5
2025
3449
0.100
Why?
Hodgkin Disease
1
2014
45
0.100
Why?
Polymerase Chain Reaction
1
2015
458
0.100
Why?
Parvoviridae Infections
1
2013
19
0.100
Why?
Parvovirus B19, Human
1
2013
16
0.100
Why?
Partial Thromboplastin Time
1
2012
14
0.100
Why?
Prothrombin Time
1
2012
18
0.100
Why?
Retrospective Studies
5
2025
6694
0.100
Why?
Cardiomyopathies
1
2014
117
0.100
Why?
Afibrinogenemia
1
2012
5
0.100
Why?
Predictive Value of Tests
1
2015
938
0.100
Why?
Immunoglobulins, Intravenous
1
2013
63
0.100
Why?
Plasma Exchange
1
2012
25
0.090
Why?
Retroperitoneal Neoplasms
1
2012
17
0.090
Why?
Gene Expression Regulation, Neoplastic
1
2016
853
0.090
Why?
Glycoproteins
1
2012
123
0.090
Why?
Precursor Cells, B-Lymphoid
1
2012
8
0.090
Why?
Histoplasma
1
2011
24
0.090
Why?
Antigens, Fungal
1
2011
19
0.090
Why?
Longitudinal Studies
2
2024
756
0.090
Why?
Immunoenzyme Techniques
1
2011
134
0.090
Why?
Hepatitis C
1
2012
80
0.090
Why?
Histoplasmosis
1
2011
48
0.090
Why?
In Situ Hybridization, Fluorescence
3
2023
262
0.080
Why?
Carcinoma, Neuroendocrine
1
2011
27
0.080
Why?
Dose-Response Relationship, Drug
2
2016
1365
0.080
Why?
Splenic Neoplasms
1
2009
2
0.080
Why?
Thyroid Neoplasms
1
2011
111
0.080
Why?
Gene Expression
1
2012
618
0.080
Why?
Myelodysplastic Syndromes
1
2009
86
0.080
Why?
Mutagenesis, Site-Directed
1
2008
100
0.070
Why?
Hemangioma
1
2009
86
0.070
Why?
Tomography, X-Ray Computed
3
2023
1140
0.070
Why?
HIV Infections
1
2012
394
0.070
Why?
Survival Analysis
2
2021
656
0.070
Why?
Protein Processing, Post-Translational
1
2008
152
0.070
Why?
Cells, Cultured
2
2008
1583
0.070
Why?
Stem Cell Transplantation
2
2022
188
0.070
Why?
Adolescent
2
2025
6713
0.060
Why?
Graft vs Host Disease
1
2007
91
0.060
Why?
Muscle Proteins
1
2008
343
0.060
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2005
34
0.060
Why?
Semaphorin-3A
1
2004
2
0.060
Why?
p38 Mitogen-Activated Protein Kinases
1
2005
94
0.060
Why?
Nerve Degeneration
1
2004
26
0.060
Why?
Acid Anhydride Hydrolases
1
2004
14
0.060
Why?
Antineoplastic Agents
1
2013
1216
0.060
Why?
Mitogen-Activated Protein Kinase 3
1
2004
47
0.060
Why?
ROC Curve
1
2025
249
0.060
Why?
Mitogen-Activated Protein Kinase 1
1
2004
48
0.060
Why?
Imidazoles
1
2005
114
0.050
Why?
Muscle, Smooth, Vascular
1
2005
135
0.050
Why?
Killer Cells, Natural
1
2024
111
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
Pyridines
1
2005
137
0.050
Why?
Gene Expression Regulation
1
2008
1004
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
Cost of Illness
1
2024
120
0.050
Why?
Pyrimidines
1
2005
199
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
140
0.050
Why?
Enzyme Inhibitors
1
2005
378
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
95
0.050
Why?
Adrenal Cortex Hormones
1
2023
116
0.050
Why?
Hippocampus
1
2004
231
0.050
Why?
Case-Control Studies
2
2019
1202
0.050
Why?
Transcriptome
1
2025
357
0.050
Why?
Cohort Studies
2
2020
1576
0.050
Why?
Dexamethasone
1
2024
434
0.040
Why?
Chromosome Aberrations
1
2023
295
0.040
Why?
Mediastinum
1
2021
21
0.040
Why?
Fever
1
2022
112
0.040
Why?
Gastrointestinal Tract
1
2022
110
0.040
Why?
Neurons
1
2004
442
0.040
Why?
T-Lymphocytes
1
2023
318
0.040
Why?
Vincristine
1
2021
89
0.040
Why?
Axilla
1
2021
92
0.040
Why?
Prednisone
1
2021
100
0.040
Why?
Pelvis
1
2021
65
0.040
Why?
Time Factors
2
2017
2987
0.040
Why?
Signal Transduction
2
2004
1724
0.040
Why?
Radiopharmaceuticals
1
2021
198
0.040
Why?
Fluorodeoxyglucose F18
1
2021
181
0.040
Why?
Cyclophosphamide
1
2021
176
0.040
Why?
Alzheimer Disease
1
2004
356
0.040
Why?
Tumor Burden
1
2020
132
0.040
Why?
Mice
3
2023
5899
0.040
Why?
Antibodies, Monoclonal
1
2023
475
0.040
Why?
Hospitalization
1
2024
731
0.040
Why?
False Negative Reactions
1
2019
31
0.040
Why?
Doxorubicin
1
2021
246
0.040
Why?
Cell Line, Tumor
1
2023
1429
0.040
Why?
Epstein-Barr Virus Infections
1
2019
31
0.040
Why?
Herpesvirus 4, Human
1
2019
43
0.040
Why?
Phosphorylation
3
2005
536
0.040
Why?
Herpesviridae Infections
1
2019
57
0.040
Why?
Genome, Viral
1
2019
79
0.040
Why?
DNA, Viral
1
2019
134
0.040
Why?
Virus Diseases
1
2019
47
0.040
Why?
Follow-Up Studies
1
2024
2294
0.040
Why?
Neoplasm Recurrence, Local
1
2022
639
0.030
Why?
Liver
1
2022
1150
0.030
Why?
Scleromyxedema
1
2016
4
0.030
Why?
Schnitzler Syndrome
1
2016
4
0.030
Why?
Cryoglobulinemia
1
2016
13
0.030
Why?
Xanthomatosis
1
2016
10
0.030
Why?
Asymptomatic Diseases
1
2016
38
0.030
Why?
POEMS Syndrome
1
2016
34
0.030
Why?
Melphalan
1
2016
176
0.030
Why?
Disease-Free Survival
1
2016
461
0.030
Why?
Young Adult
1
2025
4346
0.030
Why?
Animals
3
2023
13485
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2015
182
0.030
Why?
Thalidomide
1
2016
376
0.030
Why?
Reed-Sternberg Cells
1
2014
2
0.030
Why?
HIV Seronegativity
1
2014
3
0.030
Why?
Karyotype
1
2014
18
0.030
Why?
Fusion Proteins, bcr-abl
1
2014
20
0.030
Why?
Cell Division
2
2005
288
0.030
Why?
Heterozygote
1
2014
89
0.030
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2014
45
0.030
Why?
Mutation
1
2019
1331
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
580
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2015
412
0.030
Why?
Remission Induction
1
2014
218
0.030
Why?
Fibrinogen
1
2012
31
0.020
Why?
Risk Assessment
1
2017
1349
0.020
Why?
Blood Coagulation
1
2012
64
0.020
Why?
Survival Rate
1
2015
944
0.020
Why?
Neoplasm Staging
1
2015
768
0.020
Why?
Reference Values
1
2012
316
0.020
Why?
Biopsy
1
2014
594
0.020
Why?
Antibodies, Fungal
1
2011
2
0.020
Why?
Mycological Typing Techniques
1
2011
3
0.020
Why?
Cross Reactions
1
2011
43
0.020
Why?
Lung Diseases, Fungal
1
2011
20
0.020
Why?
Immunocompromised Host
1
2011
124
0.020
Why?
Splenectomy
1
2009
36
0.020
Why?
Severity of Illness Index
1
2012
1045
0.020
Why?
Sensitivity and Specificity
1
2011
871
0.020
Why?
Blood Transfusion
1
2009
126
0.020
Why?
Transplantation, Isogeneic
1
2007
2
0.020
Why?
Laparoscopy
1
2009
180
0.020
Why?
Mice, Inbred C3H
1
2007
80
0.020
Why?
Cyclosporine
1
2007
65
0.020
Why?
Mice, SCID
1
2007
178
0.020
Why?
Magnetic Resonance Imaging
1
2014
1507
0.020
Why?
Models, Animal
1
2007
230
0.020
Why?
Immunosuppressive Agents
1
2007
248
0.010
Why?
Macromolecular Substances
1
2004
37
0.010
Why?
Physical Chromosome Mapping
1
2004
7
0.010
Why?
tau Proteins
1
2004
31
0.010
Why?
Genetic Complementation Test
1
2004
43
0.010
Why?
Microtubule-Associated Proteins
1
2004
61
0.010
Why?
Epitopes
1
2004
62
0.010
Why?
Epidermal Growth Factor
1
2004
37
0.010
Why?
Catalytic Domain
1
2004
61
0.010
Why?
Cricetulus
1
2004
100
0.010
Why?
Mutagenesis
1
2004
58
0.010
Why?
Cloning, Molecular
1
2004
181
0.010
Why?
Cricetinae
1
2004
189
0.010
Why?
Intercellular Signaling Peptides and Proteins
1
2004
106
0.010
Why?
Receptors, Cell Surface
1
2004
111
0.010
Why?
RNA
1
2004
174
0.010
Why?
Cell Survival
1
2005
598
0.010
Why?
Amino Acid Sequence
1
2004
576
0.010
Why?
Molecular Sequence Data
1
2004
778
0.010
Why?
Nerve Tissue Proteins
1
2004
201
0.010
Why?
Mice, Inbred C57BL
1
2007
1888
0.010
Why?
Cell Line
1
2004
1020
0.010
Why?
Alapat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description